Mike Liggett

Michael Liggett brings over 30 years of experience in health care and finance. His background includes over 25 years as a CFO for private and dual listed NASDAQ/TSX companies (including 12 years as CFO of Inflazyme Pharmaceuticals) with strategic and operational expertise and proven success in finance, M&A, strategic partnerships and risk management, completing over $500 million in financing and M&A. Michael earned his chartered accountant’s designation while working at Price Waterhouse Coopers, and prior to joining Price Waterhouse Coopers, he was a practicing hospital pharmacist for 7 years.